GBA Gene Parkinson Disease Late-Onset Susceptibility to Genetic Test
Test Details
The GBA gene is associated with the development of Parkinson’s disease, particularly the late-onset form. Late-onset Parkinson’s disease typically occurs after the age of 50.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the analysis of multiple genes simultaneously. It is a powerful tool that can identify specific variations or mutations in genes, including the GBA gene, that may increase an individual’s susceptibility to late-onset Parkinson’s disease.
By analyzing the GBA gene using NGS technology, healthcare professionals can identify variations or mutations that may be present and provide information about an individual’s risk for developing Parkinson’s disease. This information can be valuable for early detection, diagnosis, and potentially for personalized treatment options or interventions.
It is important to note that genetic testing for Parkinson’s disease susceptibility is not a definitive diagnostic tool. A positive result does not guarantee the development of the disease, and a negative result does not exclude the possibility of developing Parkinson’s disease. Genetic testing should always be interpreted in conjunction with clinical symptoms and other diagnostic tests.
If you are considering genetic testing for late-onset Parkinson’s disease susceptibility, it is recommended to consult with a healthcare professional or a genetic counselor who can provide guidance and help you understand the implications of the test results.
Test Name: GBA Gene Parkinson Disease Late-Onset Susceptibility to Genetic Test
Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
- Pre Test Information: Clinical History of Patient who is going for GBA Gene Parkinson disease, late-onset, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GBA Gene Parkinson disease, late-onset, susceptibility to.
For more information or to schedule a genetic test, please contact DNA Labs UAE.
| Test Name | GBA Gene Parkinson disease late-onset susceptibility to Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for GBA Gene Parkinson disease, late-onset, susceptibility to NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GBA Gene Parkinson disease, late-onset, susceptibility to |
| Test Details |
The GBA gene is associated with the development of Parkinson’s disease, particularly the late-onset form. Late-onset Parkinson’s disease typically occurs after the age of 50. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the analysis of multiple genes simultaneously. It is a powerful tool that can identify specific variations or mutations in genes, including the GBA gene, that may increase an individual’s susceptibility to late-onset Parkinson’s disease. By analyzing the GBA gene using NGS technology, healthcare professionals can identify variations or mutations that may be present and provide information about an individual’s risk for developing Parkinson’s disease. This information can be valuable for early detection, diagnosis, and potentially for personalized treatment options or interventions. It is important to note that genetic testing for Parkinson’s disease susceptibility is not a definitive diagnostic tool. A positive result does not guarantee the development of the disease, and a negative result does not exclude the possibility of developing Parkinson’s disease. Genetic testing should always be interpreted in conjunction with clinical symptoms and other diagnostic tests. If you are considering genetic testing for late-onset Parkinson’s disease susceptibility, it is recommended to consult with a healthcare professional or a genetic counselor who can provide guidance and help you understand the implications of the test results. |
